Lauri Diehl

Company: Gilead Sciences

Job title: Executive Director - Research Pathology

Seminars:

Considering ML/AI from a Drug Development Pipeline Perspective 1:30 pm

Role of machine learning/AI changes based on needs of each stage Discovery research – building question specific ML toolkits Translational studies – leveraging ML tools to describe populations Clinical trials – ML tools and AI opportunities What do you need to understand about ML/AI? The importance of defining a scientific question endpointsRead more

day: Day One

Panel Discussion: Emerging Frontiers: The Intersection of Digital Pathology & Omics to Pioneer Unprecedented Diagnostic Capabilities 9:00 am

Exploring the synergy between digital pathology and omics in understanding diseases at a molecular level Discussing how integrating genomic data with digital pathology images enhances treatment decisions Addressing challenges and ethical considerations in managing large-scale omic and pathology datasetRead more

day: Day Two